Pale Fire Capital SE’s Neurogene NGNE Stock Holding History

Pale Fire Capital SE’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-9,460	Closed	-$298K	–	69
2026 Q2	$298K	Buy	+9,460	New	+$260K	0.02%	54

Other funds holding NGNE

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JHC

Jones Hill Capital New York $589M AUM

Pale Fire Capital SE's NGNE Position: Q3 2026 in Review

Pale Fire Capital SE sold out of Neurogene (NGNE) in Q3 2026, closing a stake of 9,460 shares — an estimated $298K sold.

Pale Fire Capital SE first reported a position in NGNE in Q2 2026 and held it in 1 quarter. The position peaked at $298K in Q2 2026. 80 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

Pale Fire Capital SE reported no remaining Neurogene position as of Q3 2026 after selling out during the quarter.
Pale Fire Capital SE sold 9,460 Neurogene shares in Q3 2026, an estimated $298K.
Pale Fire Capital SE first reported a position in Neurogene in Q2 2026 and held it in 1 quarter.
Pale Fire Capital SE's Neurogene position peaked at $298K in Q2 2026.
80 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on Pale Fire Capital SE's 13F filing for Q3 2026, filed 13 Nov 2026.